Have We Seen the End of the Line for Tax Inversion Deals?

Have We Seen the End of the Line for Tax Inversion Deals?

Assessment

Interactive Video

Business, Social Studies

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the end of corporate mergers for tax reasons, especially in the healthcare sector, due to potential regime changes in Washington. It highlights the public's perception of financial engineering as a shell game, using examples like Warren Buffett's business moves. The discussion shifts to pharmaceuticals, noting their shift from defensive to growth engines due to strong pricing and earnings, despite recent volatility in healthcare stocks.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is one reason companies in the healthcare sector were merging around 2015?

To increase their market share

To improve healthcare services

To expand internationally

To benefit from tax advantages

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the public's general perception of financial engineering strategies?

They are ignored by the public

They are considered beneficial for the economy

They are viewed as a shell game

They are seen as innovative solutions

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was Warren Buffett's strategy involving Burger King and Tim Horton's?

To merge them into a single company

To expand Tim Horton's into the US market

To move Burger King to Canada for tax benefits

To sell Tim Horton's to a competitor

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How has the pharmaceutical industry evolved over the past 20 years?

It has shifted from growth to defensive and back to growth

It has remained a defensive sector

It has become less important in the market

It has consistently been a growth sector

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a current challenge facing the pharmaceutical industry?

Decreasing demand for pharmaceuticals

High competition from new entrants

Lack of innovation

Market volatility and healthcare legislation